C0003873||Rheumatoid arthritis
C0021655||insulin resistance
C0011847||diabetes
C0376636||management
C0003873||rheumatoid arthritis
C0003873||rheumatoid arthritis
C0011847||diabetes
C0282443||review
C0003873||rheumatoid arthritis
C0011847||diabetes
C0242708||disease-modifying antirheumatic drugs
C0242708||disease-modifying antirheumatic drugs
C0011847||diabetes
C0021655||insulin resistance
C0003873||rheumatoid arthritis
C0079189||proinflammatory cytokines
C1456820||tumor necrosis factor α
C1456820||tumor necrosis factor α
C0021760||interleukin-6
C0011860||type 2 diabetes
C0003873||rheumatoid arthritis
C0242708||disease-modifying antirheumatic drugs
C0020336||hydroxychloroquine
C0025677||methotrexate
C1456820||tumor necrosis factor α
C0243076||antagonist
C0021753||interleukin-1β
C0243076||antagonists
C0184511||improve
C1513159||markers
C0596620||glucose metabolism
C0017710||glucocorticoids
C3267174||glycemic control
C0242708||DMARD
C0596620||glucose metabolism